ArticleInternational journal of biological sciences2025

PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinoma.

Peili Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.